Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2013
Filed with the SEC on Jul 23, 2013 and accepted by EDGAR at Jul 23, 2013, 16:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-01-01 to 2013-03-31 | $362.8k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-01-01 to 2013-03-31 | $115.8k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2013-01-01 to 2013-03-31 | $247.1k | us-gaap:GrossProfit |
| Operating income | 3 months2013-01-01 to 2013-03-31 | −$202.6k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2013-01-01 to 2013-03-31 | −$202.6k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-01-01 to 2013-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months2013-01-01 to 2013-03-31 | −$58.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2013-03-31 | $49.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-03-31 | $645.4k | us-gaap:AssetsCurrent |
| Total assets | At period end2013-03-31 | $670.1k | us-gaap:Assets |
| Current liabilities | At period end2013-03-31 | $567.0k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2013-03-31 | $103.1k | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001211524-13-000198. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.